BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1647495)

  • 1. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute cluster headache with sumatriptan.
    Sumatriptan Cluster Headache Study Group
    N Engl J Med; 1991 Aug; 325(5):322-6. PubMed ID: 1647496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG; D'Allens H; Richard A
    J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
    Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sumatriptan in acute migraine.
    Goadsby PJ; Zagami AS; Donnan GA; Symington G; Anthony M; Bladin PF; Lance JW
    Lancet; 1991 Sep; 338(8770):782-3. PubMed ID: 1681162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
    Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
    Ensink FB
    J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Doenicke A; Brand J; Perrin VL
    Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
    Carpay J; Schoenen J; Ahmad F; Kinrade F; Boswell D
    Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group.
    Eur Neurol; 1991; 31(5):332-8. PubMed ID: 1653141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.